Francis Collins Lawmakers Debate Stem Cell Merits
Not all stem cells are created equal. But just how close adult and reprogrammed stem cells can come to matching the capabilities of embryonic stem cells has become a contentious question in the debate over whether the federal government should continue funding research on embryonic lines. And many researchers maintain that a diverse stem cell portfolio will increase medical discovery dividends. Human embryonic stem cell (hESC) research had been backed by federal funds for more than a decade, but a surprise August injunction by a federal judge threw the field’s future into question....